8-K current report · filed Jun 25, 2026

Cytek Biosciences, Inc. (CTKB) 8-K Current Report: June 25, 2026

Item 5.02CTKB overview

Short answer

Cytek Biosciences, Inc. (CTKB) filed an 8-K current report with the SEC on June 25, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Chief Legal Officer and Corporate Secretary Valerie Barnett departing effective June 29, 2026.

Cytek Biosciences, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Chief Legal Officer and Corporate Secretary Valerie Barnett departing effective June 29, 2026
  • Separation not related to disagreements over company operations, policies, or practices
  • Legal leadership transition may affect governance and regulatory oversight continuity

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Cytek Biosciences, Inc. 8-K filings

Get the next CTKB 8-K as it lands

Follow CTKB for push alerts, or ask the research agent what this filing means.